Boxer Capital as of March 31, 2016
Portfolio Holdings for Boxer Capital
Boxer Capital holds 22 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 15.9 | $16M | 758k | 21.40 | |
| Blueprint Medicines (BPMC) | 12.5 | $13M | 705k | 18.05 | |
| Beigene (BGNE) | 12.0 | $12M | 417k | 29.31 | |
| Celator Pharmaceuticals | 9.0 | $9.2M | 835k | 11.03 | |
| Seattle Genetics | 8.0 | $8.2M | 234k | 35.09 | |
| Incyte Corporation (INCY) | 7.1 | $7.2M | 100k | 72.47 | |
| Aquinox Pharmaceuticals | 7.1 | $7.2M | 820k | 8.82 | |
| BioMarin Pharmaceutical (BMRN) | 5.7 | $5.8M | 70k | 82.49 | |
| Aradigm | 4.8 | $4.9M | 1.1M | 4.44 | |
| Syndax Pharmaceuticals (SNDX) | 3.0 | $3.1M | 234k | 13.32 | |
| Kura Oncology (KURA) | 2.6 | $2.6M | 646k | 4.05 | |
| Avexis | 2.2 | $2.3M | 83k | 27.23 | |
| Vitae Pharmaceuticals | 2.0 | $2.1M | 315k | 6.63 | |
| Akari Therapeutics | 1.9 | $2.0M | 140k | 14.00 | |
| Nabriva Therapeutics | 1.6 | $1.6M | 177k | 8.96 | |
| Eiger Biopharmaceuticals | 1.5 | $1.6M | 93k | 16.77 | |
| Zogenix | 1.5 | $1.6M | 168k | 9.24 | |
| Sophiris Bio | 0.8 | $786k | 546k | 1.44 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.5 | $511k | 155k | 3.30 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $265k | 63k | 4.20 | |
| Essa Pharma | 0.1 | $91k | 28k | 3.24 | |
| OncoGenex Pharmaceuticals | 0.1 | $60k | 88k | 0.68 |
